| Health / Medical Topics |
TRK Inhibitor AZD6918
An orally available liquid suspension containing the tropomyosin receptor kinase (Trk) inhibitor AZD6918 with potential antineoplastic activity. AZD6918 binds to Trk, thereby preventing neurotrophin-Trk interaction and Trk activation, and may eventually result in cell cycle arrest and apoptosis of tumor cells that express Trk. Trk, a receptor tyrosine kinase activated by neurotrophins, is mutated in a variety of cancer cell types and plays an important role in tumor cell growth and survival. (NCI Thesaurus)
YOU MAY ALSO LIKE
A data type comprised of the words or language units by which an entity is known.
A weakened live virus vaccine containing three seasonal influenza reassortants with prophylactic activity against influenza subtypes A and B. The trivalent live-attenuated…
A synthetic vaccine consisting of three inactivated influenza viruses, two different influenza type A strains and one influenza type B strain. Trivalent…
A derivative of cysteine with antimitotic activity and potential antineoplastic activity.
Tristetraprolin (326 aa, ~34 kDa) is encoded by the human ZFP36 gene. This protein plays a role in both RNA binding and…
A form of chromosomal variation characterized by the presence of an extra X chromosome in each cell of a human female. …
